DrugPatentWatch Database Preview
Janssen R And D Company Profile
What is the competitive landscape for JANSSEN R AND D, and when can generic versions of JANSSEN R AND D drugs launch?
JANSSEN R AND D has two approved drugs.
There are four US patents protecting JANSSEN R AND D drugs.
Summary for Janssen R And D
| US Patents: | 4 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen R And D | PARAFON FORTE DSC | chlorzoxazone | TABLET;ORAL | 011529-002 | Jun 15, 1987 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 7,887,845*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 7,037,917*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | RX | Yes | No | 7,887,845*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | RX | Yes | No | 7,037,917*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Janssen R And D Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Germany | 69929354 | ➤ Sign Up |
| Mexico | PA02003182 | ➤ Sign Up |
| Norway | 20011934 | ➤ Sign Up |
| Poland | 204427 | ➤ Sign Up |
| Estonia | 200200151 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Janssen R And D Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0373 | Netherlands | ➤ Sign Up | 300373, 20191101, EXPIRES: 20230827 |
| 2009 00004 | Denmark | ➤ Sign Up | |
| C0004 | France | ➤ Sign Up | PRODUCT NAME: ETRAVIRINE AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/08/468/001 DU 20080828; REGISTRATION NO/DATE AT EEC: EU/1/08/468/001 DU 20080828 |
| C033/2008 | Ireland | ➤ Sign Up | SPC033/2008: 20090914, EXPIRES: 20230827 |
| C/GB09/003 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB09/003 GRANTED TO JANSSEN PHARMACEUTICA NV IN RESPECT OF THE PRODUCT ETRAVIRINE OPTIONALLY IN A FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6342 DATED 08 DECEMBER 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 AUGUST 2023. |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
